For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Why minister’s good news on immunisation needs a closer look
Wednesday 28 May 2025, 12:30 AM

Good news stats on immunisation rates warrant further investigation but data is not always easy to come by [Image: Wildpixel on iStock]
The Government is celebrating a ‘steady improvement’ in childhood immunisation – but focusing on overall rates can hide who’s being left behind. Gabrielle Baker takes a deeper dive into data and reveals persistent gaps for Māori and high-needs communities
In early May, health minister Simeon Brown issued a media statement to say there has been “steady improvement in childhood immunisation rates across t, Annual childhood immunisation coverage by milestone age, deprivation and ethnicity, 1 January to 31 December 2024 , Annual childhood immunisation coverage by milestone age, deprivation and ethnicity, 1 January to 31 December 2024
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
- New Zealand Government. May 2025. See: tinyurl.com/3f3wcsus
- See: nzdoctor.co.nz/article/news/senior-hospital-doctors-strike-protest-stalled-pay-talks
- New Zealand Government. Immunisation Taskforce. 2022. See: tinyurl.com/yc7xvd4r
- Ibid.
- New Zealand Government. See: tinyurl.com/bp89mbfy
- Ibid.